Drugs for Vulvovaginal Candidiasis Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
Table of Content
1 Industrial Chain Overview
- 1.1 Drugs for Vulvovaginal Candidiasis Industry
- 1.1.1 Overview
- 1.1.2 Characteristics of Drugs for Vulvovaginal Candidiasis
- 1.2 Upstream
- 1.2.1 Major Materials
- 1.2.2 Manufacturing Overview
- 1.3 Product List By Type
- 1.3.1 Miconazole
- 1.3.2 Clotrimazole
- 1.3.3 Fluconazole
- 1.3.4 Econazole
- 1.3.5 Others
- 1.4 End-Use List
- 1.4.1 Demand in Hospital & Clinic
- 1.4.2 Demand in Pharmacy
- 1.5 Global Market Overview
- 1.5.1 Global Market Size and Forecast, 2015-2025
- 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
- 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
- 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 Global Production & Consumption by Geography
- 2.1 Global Production & Consumption
- 2.1.1 Global Production
- 2.1.2 Global Consumption
- 2.2 Geographic Production & Consumption
- 2.2.1 Production
- 2.2.1.1 Asia-Pacific
- 2.2.1.2 North America
- 2.2.1.3 South America
- 2.2.1.4 Europe
- 2.2.1.5 Middle East & Africa
- 2.2.2 Consumption
- 2.2.2.1 Asia-Pacific
- 2.2.2.2 North America
- 2.2.2.3 South America
- 2.2.2.4 Europe
- 2.2.2.5 Middle East & Africa
3 Major Manufacturers Introduction
- 3.1 Manufacturers Overview
- 3.2 Manufacturers List
- 3.2.1 Bayer Overview
- 3.2.1.1 Product Specifications
- 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.1.3 Recent Developments
- 3.2.1.4 Future Strategic Planning
- 3.2.2 Perrigo Overview
- 3.2.2.1 Product Specifications
- 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.2.3 Recent Developments
- 3.2.2.4 Future Strategic Planning
- 3.2.3 J & J Overview
- 3.2.3.1 Product Specifications
- 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.3.3 Recent Developments
- 3.2.3.4 Future Strategic Planning
- 3.2.4 Pfizer Overview
- 3.2.4.1 Product Specifications
- 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.4.3 Recent Developments
- 3.2.4.4 Future Strategic Planning
- 3.2.5 Bristol-Myers Squibb Overview
- 3.2.5.1 Product Specifications
- 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.5.3 Recent Developments
- 3.2.5.4 Future Strategic Planning
- 3.2.6 Effik Overview
- 3.2.6.1 Product Specifications
- 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.6.3 Recent Developments
- 3.2.6.4 Future Strategic Planning
- 3.2.7 Teva Overview
- 3.2.7.1 Product Specifications
- 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.7.3 Recent Developments
- 3.2.7.4 Future Strategic Planning
- 3.2.8 Sanofi Overview
- 3.2.8.1 Product Specifications
- 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.8.3 Recent Developments
- 3.2.8.4 Future Strategic Planning
- 3.2.9 Cisen Pharmaceutical Overview
- 3.2.9.1 Product Specifications
- 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.9.3 Recent Developments
- 3.2.9.4 Future Strategic Planning
- 3.2.10 Kingyork Group Overview
- 3.2.10.1 Product Specifications
- 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.10.3 Recent Developments
- 3.2.10.4 Future Strategic Planning
4 Market Competition Pattern
- 4.1 Market Size and Sketch
- 4.2 Company Market Share
- 4.2.1 Global Production by Major Manufacturers
- 4.2.2 Market Concentration Analysis
- 4.3 Market News and Trend
- 4.3.1 Merger & Acquisition
- 4.3.2 New Product Launch
5 Product Type Segment
- 5.1 Global Overview by Product Type Segment
- 5.2 Segment Subdivision by Product Type
- 5.2.1 Market in Miconazole
- 5.2.1.1 Market Size
- 5.2.1.2 Situation & Development
- 5.2.2 Market in Clotrimazole
- 5.2.2.1 Market Size
- 5.2.2.2 Situation & Development
- 5.2.3 Market in Fluconazole
- 5.2.3.1 Market Size
- 5.2.3.2 Situation & Development
- 5.2.4 Market in Econazole
- 5.2.4.1 Market Size
- 5.2.4.2 Situation & Development
- 5.2.5 Market in Others
- 5.2.5.1 Market Size
- 5.2.5.2 Situation & Development
6 End-Use Segment
- 6.1 Global Overview by End-Use Segment
- 6.2 Segment Subdivision
- 6.2.1 Market in Hospital & Clinic
- 6.2.1.1 Market Size
- 6.2.1.2 Situation & Development
- 6.2.2 Market in Pharmacy
- 6.2.2.1 Market Size
- 6.2.2.2 Situation & Development
7 Market Forecast & Trend
- 7.1 Regional Forecast
- 7.2 Consumption Forecast
- 7.2.1 Product Type Forecast
- 7.2.2 End-Use Forecast
- 7.3 Investment Trend
- 7.4 Consumption Trend
8 Price & Channel
- 8.1 Price and Cost
- 8.1.1 Price
- 8.1.2 Cost
- 8.2 Channel Segment
9 Market Drivers & Investment Environment
- 9.1 Market Drivers
- 9.2 Investment Environment
10 Research Conclusion
List of Tables
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Bayer Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Bayer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Perrigo Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Perrigo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table J & J Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of J & J (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Effik Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Effik (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Teva Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Teva (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cisen Pharmaceutical Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Cisen Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Kingyork Group Overview List
Table Drugs for Vulvovaginal Candidiasis Business Operation of Kingyork Group (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
List of Figures
Figure Drugs for Vulvovaginal Candidiasis Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Miconazole, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Miconazole, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Clotrimazole, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Clotrimazole, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Fluconazole, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Fluconazole, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Econazole, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Econazole, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hospital & Clinic, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hospital & Clinic, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Pharmacy, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Pharmacy, 2015-2018, in Volume
- 6.2.1 Market in Hospital & Clinic
- 5.2.1 Market in Miconazole
- 3.2.1 Bayer Overview
- 2.2.1 Production
According to 99Strategy, the Global Drugs for Vulvovaginal Candidiasis Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Drugs for Vulvovaginal Candidiasis market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group
Key Product Type
Miconazole
Clotrimazole
Fluconazole
Econazole
Others
Market by Application
Hospital & Clinic
Pharmacy
Main Aspects covered in the Report
Overview of the Drugs for Vulvovaginal Candidiasis market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development